Lorrain Daniel S.

Contineum Therapeutics, Inc. Class A Common Stock ยท Chief Scientific Officer

Lorrain Daniel S. is listed in public filings as officer: Chief Scientific Officer. This Lorrain Daniel S. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Contineum Therapeutics, Inc. Class A Common Stock (CTNM). Investors use Lorrain Daniel S.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Contineum Therapeutics, Inc. Class A Common StockCTNM$1.8M139.4k sharesSellJun 1, 2026$54.9K4.2k shares$13.16--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Contineum Therapeutics, Inc. Class A Common StockCTNM$2.0M143.5k sharesSellMay 1, 2026$4.2K300 shares$13.84--
Contineum Therapeutics, Inc. Class A Common StockCTNM$1.9M143.8k sharesSellMay 1, 2026$50.5K3.9k shares$13.06--
Contineum Therapeutics, Inc. Class A Common StockCTNM$2.0M147.7k sharesSellApr 6, 2026$56.0K4.2k shares$13.43--
Contineum Therapeutics, Inc. Class A Common StockCTNM$2.3M151.9k sharesSellMar 2, 2026$62.6K4.2k shares$15.01--
Contineum Therapeutics, Inc. Class A Common StockCTNM$68k67.3k sharesGrant / ExerciseFeb 25, 2026$3.9K3.8k shares$1.01--
Contineum Therapeutics, Inc. Class A Common StockCTNM$2.5M156.1k sharesSellFeb 25, 2026$61.2K3.8k shares$16.01--
Contineum Therapeutics, Inc. Class A Common StockCTNM$72k71.1k sharesGrant / ExerciseFeb 24, 2026$4.3K4.3k shares$1.01--
Contineum Therapeutics, Inc. Class A Common StockCTNM$2.5M156.1k sharesSellFeb 24, 2026$68.9K4.3k shares$16.03--
Contineum Therapeutics, Inc. Class A Common StockCTNM$2.5M156.1k sharesSellFeb 19, 2026$1.6K100 shares$16.00--
Contineum Therapeutics, Inc. Class A Common StockCTNM$76k75.4k sharesGrant / ExerciseFeb 19, 2026$101100 shares$1.01--
Contineum Therapeutics, Inc. Class A Common StockCTNM$76k75.5k sharesGrant / ExerciseFeb 11, 2026$404400 shares$1.01--
Contineum Therapeutics, Inc. Class A Common StockCTNM$2.5M156.1k sharesSellFeb 11, 2026$6.4K400 shares$16.00--
Contineum Therapeutics, Inc. Class A Common StockCTNM$2.3M157.2k sharesSellFeb 3, 2026$44.5K3k shares$14.82--
Contineum Therapeutics, Inc. Class A Common StockCTNM$2.4M156.1k sharesSellFeb 3, 2026$17.8K1.2k shares$15.25--
Contineum Therapeutics, Inc. Class A Common StockCTNM$2.3M160k sharesGrant / ExerciseJan 30, 2026$2.3M160k shares$14.26--
Contineum Therapeutics, Inc. Class A Common StockCTNM$93k6.5k sharesGrant / ExerciseJan 30, 2026$92.7K6.5k shares$14.26--
Contineum Therapeutics, Inc. Class A Common StockCTNM$1.7M160.7k sharesSellJan 5, 2026$38.0K3.7k shares$10.35--
Contineum Therapeutics, Inc. Class A Common StockCTNM$1.8M160.2k sharesSellJan 5, 2026$5.6K500 shares$11.13--
Contineum Therapeutics, Inc. Class A Common StockCTNM$2.0M164.4k sharesSellDec 23, 2025$51.0K4.2k shares$12.23--
Contineum Therapeutics, Inc. Class A Common StockCTNM$1.1M110k sharesGrant / ExerciseJan 31, 2025$1.1M110k shares$9.79--
Contineum Therapeutics, Inc. Class A Common StockCTNM$36k3.7k sharesGrant / ExerciseJan 31, 2025$36.2K3.7k shares$9.79--
Contineum Therapeutics, Inc. Class A Common StockCTNM$2.7M168.6k sharesSellNov 25, 2024$16.2K1k shares$16.02--
Contineum Therapeutics, Inc. Class A Common StockCTNM$2.9M169.6k sharesSellNov 18, 2024$1.7K99 shares$17.05--
Contineum Therapeutics, Inc. Class A Common StockCTNM$2.8M169.7k sharesSellNov 18, 2024$99.7K6.1k shares$16.37--